Figure 4.

Proportion of participants achieving weight loss ≥5% by the end of treatment, by baseline age and body mass index (BMI) subgroup, in (a) the SUSTAIN Japan monotherapy trial and (b) the SUSTAIN Japan OAD Combination trial. *Overall means are based on values from participants across all three treatment arms. Numbers of participants refer to the numbers with available target data. On‐treatment without rescue medication data in the full analysis set. Missing end‐of‐treatment data imputed from a mixed model for repeated measurements with treatment and pre‐trial treatment at screening as fixed factors and baseline value as covariate, all nested within visit, and subsequently classified. BW, bodyweight; OAD, oral antidiabetes drug; OW, once weekly.